Prenetics Global Ltd. (PRE)
21.82
-0.18
(-0.80%)
USD |
NASDAQ |
Oct 09, 16:00
21.76
-0.06
(-0.30%)
After-Hours: 20:00
Prenetics Global Shareholders Equity (Quarterly) : 93.01M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.01M |
| March 31, 2026 | 121.12M |
| December 31, 2025 | 156.46M |
| September 30, 2025 | 161.29M |
| June 30, 2025 | 150.98M |
| March 31, 2025 | 160.88M |
| December 31, 2024 | 170.39M |
| September 30, 2024 | 178.68M |
| June 30, 2024 | 188.24M |
| March 31, 2024 | 199.44M |
| December 31, 2023 | 206.36M |
| Date | Value |
|---|---|
| September 30, 2023 | 224.44M |
| June 30, 2023 | 215.31M |
| March 31, 2023 | 228.25M |
| December 31, 2022 | 237.06M |
| September 30, 2022 | 207.35M |
| June 30, 2022 | 219.09M |
| March 31, 2022 | 319.48M |
| December 31, 2021 | -400.81M |
| September 30, 2021 | 305.94M |
| June 30, 2021 | 310.04M |
| March 31, 2021 | 0.0195M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Global Cord Blood Corp. | -- |
| Exlites Holdings International, Inc. | 0.338M |
| Xcelerate, Inc. | -2.102M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Fresenius SE & Co. KGaA | 22.52B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 153.66M |
| Total Liabilities (Quarterly) | 60.73M |
| Debt to Equity Ratio | 0.0073 |
| Current Ratio | 4.039 |
| Net Debt Paydown Yield | 0.28% |